Search hospitals > Virginia > Lynchburg
Centra Lynchburg Hematology-Oncology Clinic Inc
Claim this profileLynchburg, Virginia 24501
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
103 reported clinical trials
11 medical researchers
Summary
Centra Lynchburg Hematology-Oncology Clinic Inc is a medical facility located in Lynchburg, Virginia. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Centra Lynchburg Hematology-Oncology Clinic Inc is involved with conducting 103 clinical trials across 149 conditions. There are 11 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Erin R. Alesi, and Khalid Matin.Area of expertise
1Cancer
Global LeaderStage III
Stage IV
Stage II
2Lung Cancer
Global LeaderStage III
Stage II
Stage IV
Top PIs
Andrew Poklepovic, MDVirginia Commonwealth University/Massey Cancer Center4 years of reported clinical research
Expert in Cancer
Expert in Tumors
33 reported clinical trials
82 drugs studied
Sarah W. Gordon, DOVirginia Commonwealth University/Massey Cancer Center8 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
26 reported clinical trials
54 drugs studied
Erin R. AlesiVirginia Commonwealth University/Massey Cancer Center4 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
13 reported clinical trials
19 drugs studied
Khalid MatinVirginia Commonwealth University/Massey Cancer Center4 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
13 reported clinical trials
29 drugs studied
Clinical Trials running at Centra Lynchburg Hematology-Oncology Clinic Inc
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Colorectal Cancer
Multiple Myeloma
Recurrence
Squamous Cell Carcinoma
ALK Gene Rearrangement
Lung Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Centra Lynchburg Hematology-Oncology Clinic Inc?
Centra Lynchburg Hematology-Oncology Clinic Inc is a medical facility located in Lynchburg, Virginia. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Centra Lynchburg Hematology-Oncology Clinic Inc is involved with conducting 103 clinical trials across 149 conditions. There are 11 research doctors associated with this hospital, such as Andrew Poklepovic, MD, Sarah W. Gordon, DO, Erin R. Alesi, and Khalid Matin.